ClinicalTrials.gov
ClinicalTrials.gov Menu

Neuromuscular Ultrasound for Focal Neuropathies

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01394822
Recruitment Status : Completed
First Posted : July 14, 2011
Last Update Posted : November 6, 2017
Sponsor:
Information provided by (Responsible Party):
Wake Forest University Health Sciences ( Wake Forest University )

Study Description
Go to 
Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information
Brief Summary:
The purpose of this study is to determine if a new diagnostic technique, called neuromuscular ultrasound, can improve our ability to diagnose focal nerve disease.

Condition or disease
Focal Neuropathies Carpal Tunnel Syndrome Cubital Tunnel Syndrome Median Neuropathy Ulnar Neuropathy Peroneal Neuropathy Radial Neuropathy Sciatic Neuropathy Tibial Neuropathy

Study Design
Go to 
Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Study Type : Observational
Actual Enrollment : 120 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Neuromuscular Ultrasound for Focal Neuropathies
Study Start Date : September 2011
Actual Primary Completion Date : March 2014
Actual Study Completion Date : March 2014

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Ultrasound
U.S. FDA Resources

Groups and Cohorts
Go to 
Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Group/Cohort
Ultrasound results reported
Ultrasound results NOT reported


Outcome Measures
Go to 
Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Primary Outcome Measures :
  1. Overall Neuropathy Sum Score [ Time Frame: 6 months ]
    Neuropathy specific scale


Eligibility Criteria
Go to 
Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Individuals presenting to the Diagnostic Neurology Laboratory at Wake Forest Baptist Medical Center for evaluation of focal nerve disease.
Criteria

Inclusion Criteria:

  • Electrodiagnostic finding of focal nerve disease
  • Age 18 and older

Exclusion Criteria:

  • Skin lesions preventing ultrasound
  • Known ultrasound gel allergy
  • Unable to complete 6 months of follow-up
Contacts and Locations
Go to 
Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01394822


Locations
United States, North Carolina
Wake Forest Baptist Medical Center
Winston-Salem, North Carolina, United States, 27157
Sponsors and Collaborators
Wake Forest University
Investigators
Principal Investigator: Michael S Cartwright Wake Forest University Health Sciences
More Information
Go to 
Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Responsible Party: Wake Forest University
ClinicalTrials.gov Identifier: NCT01394822     History of Changes
Other Study ID Numbers: NINDS-K23NS062892
First Posted: July 14, 2011    Key Record Dates
Last Update Posted: November 6, 2017
Last Verified: December 2014

Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No

Additional relevant MeSH terms:
Nerve Compression Syndromes
Ulnar Nerve Compression Syndromes
Syndrome
Peripheral Nervous System Diseases
Carpal Tunnel Syndrome
Cubital Tunnel Syndrome
Ulnar Neuropathies
Median Neuropathy
Sciatic Neuropathy
Radial Neuropathy
 Peroneal Neuropathies
Tibial Neuropathy
Disease
Pathologic Processes
Neuromuscular Diseases
Nervous System Diseases
Mononeuropathies
Cumulative Trauma Disorders
Sprains and Strains
Wounds and Injuries